Skip to main content

Table 1 Patients characteristics

From: Nasal high–flow oxygen therapy in patients with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation (NIV)

No

Diagnosis

Age

BMI [kg/m2]

SAPS II

Baseline O2-flow

Measurement in days after ICU-admission

Mech. venti. during ICU stay (no/after the study)

Hospital survival

[years]

[L/min]

1

Idiopathic pneumonia syndrome

29

27

56

10

0

1 day, after

No

2

Pneumonia (respiratory syncytial virus)

69

34

55

7

6

no

Yes

3

Pneumonia (Strep. pneumoniae)

82

21

29

8

10

no

Yes

4

Pneumonia

72

30

36

6

1

no

Yes

5

Pneumonia (Staph. aureus)

78

30

48

12

15

no

Yes

6

Pneumonia, pleural mesothelioma

71

26

54

4

1

no

Yes

7

Pneumonia

76

28

55

6

0

no

Yes

8

Pneumonia

50

25

45

6

1

no

Yes

9

Adenocarcinoma lung

59

19

29

7

7

11 days, after

No

10

Respiratory failure, myelodysplastic syndrome

68

30

43

5

6

no

Yes

11

Connective tissue disease

38

29

15

8

0

no

Yes

12

Pneumonia

28

29

32

5

1

no

Yes

13

Pneumonia (influenza H1N1)

45

22

37

4

2

no

Yes

14

Alveolar hemorrhage

18

24

43

5

4

no

Yes

  1. BMI body mass index, SAPS II Simplified Acute Physiology Score II.